MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
debentures
$11,866,293
Proceeds from warrant
exercises
$9,874,998
Proceeds from issuance of
common stock
$9,790,015
Represents the amount of
proceeds from issuance of...
$8,427,416
Proceeds from stock
options exercised
$162,400
Net cash provided by
financing activities
$31,939,785
Canceled cashflow
$8,181,337
Cash, cash
equivalent, restricted...
$4,540,895
Canceled cashflow
$27,398,890
Repayment of new debenture
$7,391,107
Issuance costs for common
shares
$653,504
Costs to issue
debentures
$136,726
Research and development
expense (excluding...
$8,717,475
Stock-based compensation
expense
$1,512,194
Increase (decrease) in
accounts payable, trade
$923,552
Represents the amount of
change in fair value of...
$583,823
Paid-in-kind interest
$429,061
Prepaid expenses
-$352,825
Represents the amount of
increase decrease in...
$300,000
Represents the amount of
gain loss on...
-$278,854
Represents the amount of
costs to issue...
$111,725
Represents the amount of
operating lease...
$97,838
Foreign exchange
gain/loss
-$41,947
Repayment of debentures on
extinguishment
-$25,000
Net cash used in
operating activities
-$22,776,769
Cash provided by
(used in) investing...
-$4,619,152
Effect of exchange rate
on cash, cash...
-$2,969
Canceled cashflow
$13,374,294
Net loss for the year
-$35,444,361
Represents the amount of net
cash paid for antev...
$4,619,152
Increase (decrease) in
accounts payable and...
-$438,802
Increase (decrease) in
operating lease liability
-$142,612
Deferred financing costs
$99,305
Increase (decrease) in
accounts payable,...
-$25,983
Back
Back
Cash Flow
source: myfinsight.com
Medicus Pharma Ltd. (MDCXW)
Medicus Pharma Ltd. (MDCXW)